Wed, Jul 23, 2014, 1:19 AM EDT - U.S. Markets open in 8 hrs 11 mins


% | $
Click the to save as a favorite.

Agenus Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • kenrp713 kenrp713 Sep 16, 2012 8:56 PM Flag

    we need our old long supporter

    Slide #6 - "annual peak royalty potential over one hundred million". Agenus will receive some percentage of total sales in royalties from the vaccines containing QS-21 for up to ten years after commercialization. We do not know the percentages - but slide #4 represents the total opportunity for each vaccine (billions), Agenus' total potential (royalties) on each of these is some small percentage of sales.

    "over one hundred million" is still a lot of money for a company whose current market cap is just over one hundred million. This does not include the potential of more future vaccines (indications) for QS-21 above and beyond the ones currently under contract.

    Also, the profit margin on this is HUGE - almost no or little expense to generate this money - the pharmaceutical company selling the vaccines bears all the burden for the cost of sales, marketing, and distribution.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
3.05+0.09(+3.04%)Jul 22 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.